Company / Total Assets
Boston Scientific Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$43.7B
FY2025
5-year range
$32.2B / $43.7B
FY2021-FY2025
Trend
+10.9%
vs FY2024
Sector context
#16 of 161
Health Care
What the data says
Among 161 Health Care companies, Boston Scientific is in the top 10% for total assets. Total Assets has increased for 9 consecutive years, from $18.1B in FY2016 to $43.7B in FY2025.
Based on SEC 10-K filings.
$43.7B in FY2025 with a 5-year CAGR of +7.3%. Top quartile in the Health Care sector.
Improved from $35.1B to $43.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- +7.3%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 161This company $43.7B Sector average $14.8B
▼
+195.7% above sector average
Key checks
Key Insights
- Boston Scientific's total assets has grown for 9 consecutive years.
- 5-year CAGR of +7.3%, indicating consistent growth.
- In FY2025, total assets increased 10.9% year-over-year.
- Ranks #16 out of 161 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $43.7B | +10.9% |
| FY2024 | $39.4B | +12.1% |
| FY2023 | $35.1B | +8.2% |
| FY2022 | $32.5B | +0.7% |
| FY2021 | $32.2B | +4.7% |
| FY2020 | $30.8B | +0.7% |
| FY2019 | $30.6B | +45.6% |
| FY2018 | $21.0B | +10.3% |
| FY2017 | $19.0B | +5.2% |
| FY2016 | $18.1B | -0.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026